0
News and events Contact us

hemaPEN technical information

Home   hemaPEN technical information   Page 1 of 1

Advanced precision microsamplinghemaPEN

Confident and accurate results begin with hemaPEN.

hemaPEN® is a microsampling tool that enables the collection of four volumetrically fixed, accurate and precise, samples from a single source.

Where there is no option to compromise, the hemaPEN is designed to maintain sample integrity for quantitative analysis and enable information-rich decision making.

hemaPEN is an easy to use advanced precision microsampling tool that can be used by anyone in any place.

View available hemaPEN models for your location:

Australia and New Zealand Rest of world

Interested in hemaPEN and microsampling innovations?

Sign up for hemaPEN updates

 

Technical Poster - Improved dried blood spot-based metabolomics using a novel microsampling device

hemaPEN®

Download: Technical Poster - Improved dried blood spot-based metabolomics using a novel microsampling device [PDF]

hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490.
Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.

View full product details
 

Poster - Blood sampling made easy

hemaPEN®

Download: Poster - Blood sampling made easy [PDF]

Author: Australian National Fabrication Facility (ANFF).

View full product details
 

Technical Poster - Volumetrically accurate samples via a novel dried blood spot sampling technique

hemaPEN®

Download: Technical Poster - Volumetrically accurate samples via a novel dried blood spot sampling technique [PDF]

hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.

View full product details
 

Technical Poster - Metabolomics/lipidomics of dried blood spots using a novel blood microsampling device (hemaPEN®)

hemaPEN®

Download: Technical Poster - Metabolomics/lipidomics of dried blood spots using a novel blood microsampling device (hemaPEN®) [PDF]

hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.

View full product details

 

Technical Poster - Incorporating novel synthetic DBS substrates into a blood microsampling device for multi-omics analyses

hemaPEN®

Download: Technical Poster - Incorporating novel synthetic DBS substrates into a blood microsampling device for multi-omics analyses [PDF]

hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.

View full product details
 

Technical Poster - Collection and storage of volumetrically accurate and precise dried blood spots in a contained device: hemaPEN

hemaPEN®

Download: Technical Poster - Collection and storage of volumetrically accurate and precise dried blood spots in a contained device: hemaPEN [PDF]

hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.

View full product details